Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as p
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this head and neck cancer clinical trial in Little Rock, AR
If you're searching for head and neck cancer treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.